ESR1 and bone metastasis: The choice of method (such as IHC and RT-PCR), the assay method (dual-antibody vs single-antibody ER assay), as well as sample processing (e.g., decalcification reduced staining intensity especially in bone metastasis) may yield to discordant results [29–31].